Adma Biologics ADMA
NASDAQ ADMA
$10.03 +0.07 (+0.75%)
As of: Sep 30, 2026 · 3:59 PM EDT

Adma Biologics (ADMA) Preferred Shares (2011)

Updated

Adma Biologics (ADMA) posted Preferred Shares of $8,222 for Q4 2011.

Analysis

Adma Biologics (ADMA) Preferred Shares (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Adma Biologics 2.24 Bn 1.82 Bn 86.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 8,222.00
API Access

Adma Biologics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=ADMA&period=max&api_key=YOUR_API_KEY